Vancouver, B.C. – September 24, 2014 – The first baby in Canada conceived with the assistance of the Early Embryo Viability Assessment (Eeva®) Test at Vancouver’s Genesis Fertility Centre was born this past August. Olivia, born to Darla Macey-Nicholson and Craig Nicholson, was conceived through in vitro fertilization (IVF) with the help of novel embryo development information provided by the Eeva®Test.
The Eeva® Test, which is exclusively distributed in Canada by EMD Serono, a division of EMD Inc., Canada, is a significant innovation for reproductive technology. The test is a tool which helps embryologists in assessing the embryo most likely to develop for implantation, ultimately aiding fertility experts achieve better outcomes for their patients. Developed by Auxogyn Inc., a company dedicated to advancing women’s reproductive health, the Eeva® Test is based on patented technology developed by StanfordUniversity researchers. This team of university researchers is world-renowned for pioneering techniques in time-lapse imaging of stem cells.
“We are honoured to have helped conceive the first Eeva® baby in Canada,” says Dr. Sonya Kashyap MD, medical director of Genesis Fertility Centre. “It demonstrates that Eeva can act as a tool to improve success rates of IVF in addition to increasing patients’ overall experience to achieve pregnancy. These are our two most important goals.”